Skip to main content
. Author manuscript; available in PMC: 2019 Dec 7.
Published in final edited form as: Circ Res. 2018 Dec 7;123(12):1258–1260. doi: 10.1161/CIRCRESAHA.118.314185

Figure 1.

Figure 1.

Transgenic (Tg) overexpression of a poison Mybpc340kDa peptide fragment in a cardiomyocyte (CM)-specific manner leads to hypertrophic cardiomyopathy and heart failure, characterized by severe fibrosis. Myofibroblast (MyoFB)-specific deletion of Tgfbr2 decreases fibrosis and improves cardiac function and survival, despite continued presence of the toxic peptide. FB=Fibroblasts. MCM=Mer-Cre-Mer.